At 6 mg/mL, 2.4 mg equals 0.4 mL, or 40 units
Injecting it subcutaneously into the abdomen or rotating general sites misses its primary benefit local tissue repair and growth
Cover Image Credit: Adamr / 123RF.com (Licensed)
Patients with a history of pancreatitis, gallbladder disease, or severe gastroparesis may require careful consideration of risks versus benefits
Blumenstein I, Herrmann E, Filmann N, Zosel C, Tacke W, Bock H, Dignass A, Hartmann F, Zeuzem S, Stein J, Schrder O
Initial Treatment Phase Starting semaglutide involves an initial phase where the dosage is gradually increased to minimize potential side effects such as nausea and gastrointestinal discomfort